Dinuclear copper-based compound and ligand for nucleic acid scission and anticancer treatment
The present invention is related to a novel method for splitting nucleic acids at specific points on a complementary nucleic acid segment using a dinuclear copper-based compound of Formula I. Additionally, the present invention is related to a novel treatment of cancer, tumors, and cancer cells using a dinuclear copper-based compound of Formula I or a naked ligand of formula II: (Formula I and II).
1. A method of treating a cancer selected from the group consisting of leukemia, non-small cell lung cancer, colon cancer, central nervous system cancer, melanoma, ovarian cancer, renal cancer, ovarian cancer, cancer of the head and neck, bladder cancer, small cell cancer of the lung, squamous-cell carcinomas of the head, neck, esophagus, skin, and the genitourinary tract, including the cervix, vulva, scrotum, and penis, prostate cancer, and breast cancer, in a patient in need thereof, said method comprising administering to a patient a cancer-treating effective amount of a compound of formula (I), wherein the compound of formula (I) is:
and wherein PY is 2-pyridyl.
2. A method of treating a cancer tumor, wherein the cancer tumor is selected from the group consisting of leukemia tumor, non-small cell lung tumor, colon cancer tumor, central nervous system cancer tumor, melanoma tumor, ovarian cancer tumor, renal cancer tumor, ovarian cancer tumor, cancer tumors of the head and neck, bladder cancer tumor, small cell cancer tumor of the lung, squamous-cell carcinoma tumors of the head, neck, esophagus, skin, and the genitourinary tract, including the cervix, vulva, scrotum, and penis, prostate cancer tumor, and breast cancer tumor, said method comprising administering to the cancer tumor a cancer tumor-treating effective amount of a compound of formula (I), wherein the compound of formula (I) is:
and wherein PY is 2-pyridyl.
3. A method of treating cancer cells, wherein the cancer cells selected from the group consisting of leukemia cells, non-small cell lung cancer cells, colon cancer cells, central nervous system cancer cells, melanoma cells, ovarian cancer cells, renal cancer cells, ovarian cancer cells, cancer cells of the head and neck, bladder cancer cells, small cell cancer cells of the lung, squamous-cell carcinoma cells of the head, neck, esophagus, skin, and the genitourinary tract, including the cervix, vulva, scrotum, and penis, prostate cancer cells, and breast cancer cells, said method comprising administering to the cancer cells a cancer cell-treating effective amount of a compound of formula (I), wherein the compound of formula (I) is:
and wherein PY is 2-pyridyl.
4. A method of splitting a nucleic acid segment at a specific position thereon, wherein said method comprises
(a) providing a nucleic acid segment having (i) an n position, wherein said n position is (a) the first unpaired position on the 3′ overhang of the nucleic acid segment, (b) adjacent to the point of scission, and (c) occupied by a guanine residue, and (ii) an x position, wherein said x position is (a) the first unpaired position on the 5′ overhang of the nucleic acid segment, (b) adjacent to the point of scission, and (c) occupied by an adenine residue; and (iii) an n+1 position wherein said n+1 position is the point of scission and is the first unpaired residue that is adjacent to the n position;
(b) contacting the nucleic acid segment with a compound of formula (I) for a time sufficient to split the nucleic acid at the n+1 position of the nucleic acid segment, wherein the compound of formula (I) is:
and wherein PY is 2-pyridyl.
5. A method of treating a cancer selected from the group consisting of leukemia, non-small cell lung cancer, colon cancer, central nervous system cancer, melanoma, ovarian cancer, renal cancer, ovarian cancer, cancer of the head and neck, bladder cancer, small cell cancer of the lung, squamous-cell carcinomas of the head, neck, esophagus, skin, and the genitourinary tract, including the cervix, vulva, scrotum, and penis, prostate cancer, and breast cancer, in a patient in need thereof, said method comprising administering to a patient a cancer-treating effective amount of a compound of formula (II), wherein the compound of formula (II) is:
6. A method of treating a cancer tumor, wherein the cancer tumor is selected from the group consisting of leukemia tumor, non-small cell lung cancer tumor, colon cancer tumor, central nervous system cancer tumor, melanoma tumor, ovarian cancer tumor, renal cancer tumor, ovarian cancer tumor, cancer tumors of the head and neck, bladder cancer tumor, small cell cancer tumor of the lung, squamous-cell carcinoma tumors of the head, neck, esophagus, skin, and the genitourinary tract, including the cervix, vulva, scrotum, and penis, prostate cancer tumor, and breast cancer tumor, said method comprising administering to the cancer tumor a cancer tumor-treating effective amount of a compound of formula (II),
wherein the compound of formula (II) is:
7. A method of treating cancer cells, wherein the cancer cells selected from the group consisting of leukemia cells, non-small cell lung cancer cells, colon cancer cells, central nervous system cancer cells, melanoma cells, ovarian cancer cells, renal cancer cells, ovarian cancer cells, cancer cells of the head and neck, bladder cancer, small cell cancer cells of the lung, squamous-cell carcinoma cells of the head, neck, esophagus, skin, and the genitourinary tract, including the cervix, vulva, scrotum, and penis, prostate cancer cells, and breast cancer cells, said method comprising administering to the cancer cells a cancer cell-treating effective amount of a compound of formula (II), wherein the compound of formula (II) is: